Danen Technology Corp
TWSE:3686
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Danen Technology Corp
TWSE:3686
|
TW |
|
B
|
Bristol-Myers Squibb Co
XETRA:BRM
|
US |
|
O
|
Octodec Investments Ltd
JSE:OCT
|
ZA |
|
S
|
Square Enix Holdings Co Ltd
TSE:9684
|
JP |
|
J
|
Jushi Holdings Inc
CNSX:JUSH
|
US |
|
Hyzon Motors Inc
NASDAQ:HYZN
|
US |
|
I
|
InfuSystem Holdings Inc
AMEX:INFU
|
US |
|
H
|
Hargreaves Services PLC
XBER:H6W
|
UK |
|
Danone SA
OTC:GPDNF
|
FR |
|
Genesis Healthcare Inc
OTC:GENN
|
US |
|
Garb Oil & Power Corp
OTC:GARB
|
US |
Balance Sheet
Balance Sheet Decomposition
Danen Technology Corp
Danen Technology Corp
Balance Sheet
Danen Technology Corp
| Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Cash & Cash Equivalents |
237
|
84
|
195
|
1 235
|
2 546
|
1 179
|
565
|
954
|
903
|
876
|
705
|
434
|
259
|
198
|
561
|
42
|
8
|
16
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
565
|
354
|
303
|
186
|
131
|
65
|
17
|
27
|
561
|
5
|
8
|
10
|
|
| Cash Equivalents |
237
|
84
|
195
|
1 235
|
2 546
|
1 179
|
0
|
600
|
600
|
690
|
574
|
369
|
243
|
172
|
0
|
37
|
0
|
7
|
|
| Short-Term Investments |
0
|
242
|
196
|
89
|
0
|
28
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
96
|
559
|
665
|
454
|
|
| Total Receivables |
0
|
0
|
67
|
246
|
171
|
37
|
141
|
205
|
161
|
73
|
54
|
2
|
1
|
1
|
0
|
68
|
30
|
19
|
|
| Accounts Receivables |
0
|
0
|
57
|
227
|
147
|
24
|
131
|
195
|
141
|
71
|
51
|
0
|
0
|
0
|
0
|
67
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
11
|
19
|
24
|
13
|
10
|
10
|
20
|
2
|
3
|
2
|
1
|
0
|
0
|
0
|
30
|
19
|
|
| Inventory |
0
|
186
|
125
|
327
|
103
|
85
|
115
|
191
|
171
|
138
|
112
|
31
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
78
|
135
|
85
|
167
|
144
|
74
|
42
|
19
|
13
|
45
|
43
|
9
|
676
|
576
|
0
|
0
|
1
|
1
|
|
| Total Current Assets |
315
|
647
|
667
|
2 064
|
2 964
|
1 403
|
863
|
1 369
|
1 247
|
1 133
|
914
|
476
|
936
|
775
|
658
|
669
|
704
|
491
|
|
| PP&E Net |
0
|
1 027
|
1 243
|
3 377
|
4 619
|
4 560
|
4 403
|
3 845
|
3 359
|
2 761
|
2 176
|
753
|
116
|
93
|
7
|
5
|
2
|
8
|
|
| PP&E Gross |
0
|
1 027
|
1 243
|
3 377
|
4 619
|
4 560
|
4 403
|
3 845
|
3 359
|
2 761
|
2 176
|
753
|
116
|
93
|
7
|
5
|
2
|
8
|
|
| Accumulated Depreciation |
0
|
7
|
79
|
274
|
697
|
1 151
|
1 619
|
2 154
|
2 688
|
3 237
|
3 779
|
5 054
|
184
|
181
|
1
|
1
|
1
|
2
|
|
| Long-Term Investments |
0
|
4
|
4
|
7
|
11
|
174
|
275
|
11
|
11
|
11
|
166
|
166
|
156
|
158
|
77
|
69
|
5
|
213
|
|
| Other Long-Term Assets |
0
|
48
|
105
|
23
|
194
|
343
|
359
|
301
|
219
|
8
|
6
|
1
|
60
|
60
|
60
|
1
|
1
|
1
|
|
| Total Assets |
315
N/A
|
1 725
+448%
|
2 018
+17%
|
5 470
+171%
|
7 787
+42%
|
6 479
-17%
|
5 901
-9%
|
5 527
-6%
|
4 837
-12%
|
3 913
-19%
|
3 262
-17%
|
1 396
-57%
|
1 267
-9%
|
1 086
-14%
|
801
-26%
|
743
-7%
|
712
-4%
|
713
+0%
|
|
| Liabilities | |||||||||||||||||||
| Accounts Payable |
0
|
29
|
47
|
367
|
103
|
24
|
113
|
194
|
193
|
87
|
162
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
1
|
25
|
43
|
158
|
83
|
44
|
0
|
0
|
0
|
33
|
28
|
12
|
4
|
4
|
23
|
4
|
4
|
4
|
|
| Short-Term Debt |
0
|
653
|
66
|
52
|
185
|
311
|
220
|
0
|
0
|
0
|
25
|
55
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
106
|
332
|
755
|
1 001
|
517
|
90
|
75
|
25
|
23
|
23
|
23
|
23
|
2
|
2
|
2
|
3
|
|
| Other Current Liabilities |
0
|
89
|
42
|
418
|
153
|
13
|
136
|
106
|
100
|
48
|
38
|
54
|
70
|
82
|
7
|
1
|
1
|
0
|
|
| Total Current Liabilities |
2
|
796
|
304
|
1 327
|
1 278
|
1 393
|
986
|
391
|
368
|
193
|
275
|
144
|
97
|
110
|
32
|
7
|
7
|
7
|
|
| Long-Term Debt |
0
|
0
|
326
|
1 005
|
1 725
|
1 079
|
643
|
124
|
58
|
43
|
0
|
8
|
90
|
68
|
4
|
2
|
0
|
5
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
3
|
3
|
6
|
4
|
4
|
4
|
5
|
5
|
110
|
143
|
122
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
2
N/A
|
796
+52 947%
|
630
-21%
|
2 334
+271%
|
3 006
+29%
|
2 478
-18%
|
1 632
-34%
|
519
-68%
|
430
-17%
|
240
-44%
|
280
+17%
|
261
-7%
|
330
+27%
|
300
-9%
|
37
-88%
|
9
-75%
|
7
-26%
|
12
+76%
|
|
| Equity | |||||||||||||||||||
| Common Stock |
315
|
910
|
1 260
|
1 645
|
2 037
|
2 037
|
2 648
|
3 497
|
3 496
|
3 496
|
3 496
|
3 496
|
1 135
|
1 135
|
1 135
|
765
|
765
|
765
|
|
| Retained Earnings |
2
|
253
|
353
|
479
|
74
|
780
|
625
|
537
|
604
|
734
|
691
|
2 361
|
199
|
350
|
370
|
31
|
60
|
65
|
|
| Additional Paid In Capital |
0
|
60
|
340
|
1 012
|
2 819
|
2 745
|
2 254
|
0
|
1 514
|
910
|
176
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
212
|
142
|
0
|
0
|
0
|
9
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
313
N/A
|
929
+197%
|
1 389
+49%
|
3 136
+126%
|
4 781
+52%
|
4 001
-16%
|
4 268
+7%
|
5 008
+17%
|
4 406
-12%
|
3 673
-17%
|
2 982
-19%
|
1 135
-62%
|
936
-18%
|
785
-16%
|
765
-3%
|
734
-4%
|
705
-4%
|
700
-1%
|
|
| Total Liabilities & Equity |
315
N/A
|
1 725
+448%
|
2 018
+17%
|
5 470
+171%
|
7 787
+42%
|
6 479
-17%
|
5 901
-9%
|
5 527
-6%
|
4 837
-12%
|
3 913
-19%
|
3 262
-17%
|
1 396
-57%
|
1 267
-9%
|
1 086
-14%
|
801
-26%
|
743
-7%
|
712
-4%
|
713
+0%
|
|
| Shares Outstanding | |||||||||||||||||||
| Common Shares Outstanding |
4
|
10
|
13
|
18
|
22
|
22
|
26
|
37
|
114
|
76
|
76
|
76
|
76
|
76
|
76
|
76
|
76
|
76
|
|